Identification of novel small molecule ligands that bind to tetanus toxin

Chemical Research in Toxicology

Volumn 13, Issue 5, 2000, Pages 356-362

  Lightstone, Felice C ^a   Prieto, Maria C ^a   Singh, Anup K ^b   Piqueras, Mari Carmen ^b   Whittal, Randy M ^c   Knapp, Mark S ^a   Balhorn, Rod ^a   Roe, Diana C ^b  

^a LAWRENCE LIVERMORE NATIONAL LABORATORY   (United States)

^b SANDIA NATIONAL LABORATORIES   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; DOXORUBICIN; LIGAND; LIPOSOME; TETANUS TOXIN;

ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; HYDROPHOBICITY; LIGAND BINDING; MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN BINDING;

BINDING SITES; COMPUTER SIMULATION; DOXORUBICIN; LIGANDS; LIPOSOMES; MASS SPECTROMETRY; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PEPTIDE FRAGMENTS; TETANUS TOXIN;

EID: 0034074081     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx000009e     Document Type: Article

References (48)

1. Montecucco, C. (1995) Clostridial Neurotoxins. The Molecular Pathogenesis of Tetanus and Botulism. In Current Topics in Microbiology and Immunology, Vol. 195, Springer-Verlag, Berlin.
2. Blasi, J., Chapman, E. R., Link, E. P., Binz, T., Yamasaki, S., DeCamill, P., Sudhof, T. C., Niemann, H., and Jahn, R. (1993) Botulinum Neurotoxin-A Selectively Cleaves the Synaptic Protein SNAP-25. Nature 365, 160-163.
3. Schiavo, G., Benfenati, F., Poulain, B., Rossetto, O., Laureto, P. P. d., DasGupta, B. R., and Montecucco, C. (1992) Tetanus and Botulinum-B Neurotoxins Block Neurotransmitter Release by Proteolytic Cleavage of Synaptobrevin. Nature 359, 832-835.
4. Rogers, T. B., and Snyder, S. H. (1981) High Affinity Binding of Tetanus Toxin to Mammalian Brain Membranes. J. Biol. Chem. 236, 2402-2407.
5. Morris, N. P., Consiglio, E., Kohn, L. D., Habig, W. H., Hardegree, M. C., and Helting, T. B. (1980) Interaction of Fragments B and C of Tetanus Toxin with Neural and Thyroid Membranes and with Gangliosides. J. Biol. Chem. 255, 6071-6076.
6. Holmgren, J., Elwing, H., Fredman, P., and Svennerholm, L. (1980) Polystyrene-Adsorbed Gangliosides for Investigation of the Structure of the Tetanus-Toxin Receptor. Eur. J. Biochem. 106, 371-379.
7. Winter, A., Ulrich, W. P., Wetterich, F., Weller, U., and Galla, H. J. (1996) Gangliosides in Phospholipid-Bilayer Membranes: Interaction with Tetanus Toxin. Chem. Phys. Lipids 81, 21-34.
8. Halpern, J. L., and Loftus, A. (1993) Characterization of the Receptor-Binding Domain of Tetanus Toxin. J. Biol. Chem. 268, 11188-11192.
9. Shapiro, R. E., Specht, C. D., Collins, B. E., Woods, A. S., Cotter, R. J., and Schnaar, R. L. (1997) Identification of a Ganglioside Recognition Domain of Tetanus Toxin Using a Novel Ganglioside Photoaffinity Ligand. J. Biol. Chem. 272, 30380-30386.
10. Atassi, M. Z., and Oshima, M. (1999) Structure, Activity, and Immune (T and B Cell) Recognition of Botulinum Neurotoxins. Crit. Rev. Immunol. 19, 219-260.
11. Henderson, D. A. (1999) The Looming Threat of Bioterrorism. Science 283, 1279-1282.
12. Pearson, G. S. (1998) The Threat of Deliberate Disease in the 21st Century. In Biological Weapons Proliferation: Reasons for Concern, Courses of Action, Report 24, Henry L. Stimson Center, Washington, DC.
13. Lacy, D. B., Tepp, W., Cohen, A. C., DasGupta, B. R., and Stevens, R. C. (1998) Crystal Structure of Botulinum Neurotoxin Type A and Implications for Toxicity. Nat. Struct. Biol. 5, 898-902.
14. Knapp, M., Segelke, B., and Rupp, B. (1998) The 1.61 Angstrom Structure of the Tetanus Toxin Ganglioside Binding Region: Solved by MAD and Mir Phase Combination. Am. Crystallogr. Assoc. 25, 90.
15. c of Tetanus Neurotoxin. Nat. Struct. Biol. 4, 788-792.
16. Ewing, T. J. A., and Kuntz, I. D. (1997) Critical Evaluation of Search Algorithms for Automated Molecular Docking and Database Screening. J. Comput. Chem. 18, 1175-1189.
17. DesJarlais, R. L., Sheridan, R. P., Seibel, G. L., Dixon, J. S., Kuntz, I. D., and Venkataraghavan, R. (1988) Using Shape Complementarity as an Initial Screen in Designing Ligands for a Receptor Binding Site of Known Three-Dimensional Structure. J. Med. Chem. 31, 722-729.
18. Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., and Ferrin, T. E. (1982) A Geometric Approach to Macromolecule-Ligand Interactions. J. Mol. Biol. 161, 269-288.
19. Meng, E. C., Shoichet, B. K., and Kuntz, I. D. (1992) Automated Docking with Grid-Based Energy Evaluation. J. Comput. Chem. 13, 505-524.
20. Available Chemicals Directory (1997) version 97.2, Molecular Design, Inc., San Leandro, CA.
21. Gasteiger, J., and Marsili, M. (1978) A New Model For Calculating Atomic Charges In Molecules. Tetrahedron Lett. 34, 3181-3184.
22. Gasteiger, J., and Marsili, M. (1980) Iterative Partial Equalization of Orbital Electronegativity: A Rapid Access to Atomic Charges. Tetrahedron 36, 3219-3288.
23. Gasteiger, J., and Marsili, M. (1981) Prediction of Proton Magnetic Resonance Shifts: The Dependence on Hydrogen Charges Obtained by Iterative Partial Equalization of Orbital Electronegativity. Org. Magn. Reson. 15, 353-360.
24. Sybyl (1997) Tripos, Inc., St. Louis, MO.
25. Meng, E. C. (1993) Ph.D. Thesis, School of Pharmacy, University of California, Berkeley, CA.
26. Weiner, S. J., Kollman, P. A., Case, D. A., Singh, U. C., Ohio, C., Alagona, G., Profeta, S., and Weiner, P. (1984) A New Force-Field For Molecular Mechanical Simulation of Nucleic-Acids and Proteins. J. Am. Chem. Soc. 106, 765-784.
27. DesJarlais, R. L., Sheridan, R. P., Dixon, S., Kuntz, I. D., and Venkataraghavan, R. (1986) Docking Flexible Ligands to Macromolecular Receptors by Molecular Shape. J. Med. Chem. 29, 2149-2153.
28. Greig, M. J., Gaus, H., Cummins, L. L., Sasmor, H., and Griffey, R. H. (1995) Measurement of Macromolecular Binding Using Electrospray Mass Spectrometry. Determination of Dissociation Constants for Oligonucleotide-Serum Albumin Complexes. J. Am. Chem. Soc. 117, 10765-10766.
29. Mayer, L. D., Hope, M. J., and Cullis, P. R. (1986) Vesicles of Variable Sizes Produced by a Rapid Extrusion Procedure. Biochim. Biophys. Acta 858, 161-168.
30. Provencher, S. W. (1982) CONTIN: A General Purpose Constrained Regularization Program for Inverting Noisy Linear Algebraic or Integral Equations. Comput. Phys. Commun. 27, 229-242.
31. Singh, A. K., Kilpatrick, P. K., and Carbonell, R. G. (1996) Application of Antibody and Fluorophore-Derivatized Liposomes to Heterogeneous Immunoassays for D-dimer. Biotechnol. Prog. 12, 272-280.
32. Rutenber, E., Fauman, E. B., Keenan, R. J., Fong, S., Furth, P. S., Montellano, P. R. O. d., Meng, E., Kuntz, I. D., DeCamp, D. L., Salto, R., Rosé, J. R., Craik, C. S., and Stroud, R. M. (1993) Structure of a Non-peptide Inhibitor Complexed with HIV-1 Protease. J. Biol. Chem. 268, 15343-15346.
33. Desjarlais, R. L., Seibel, G. L., Kuntz, I. D., Furth, P. S., Alvarez, J. C., Montellano, P. R. O. d., DeCamp, D. L., Babé, L. M., and Craik, C. S. (1990) Structure-Based Design of Nonpeptide Inhibitors Specific for the Human Immunodeficiency Virus 1 Protease. Proc. Natl. Acad. Sci. U.S.A. 87, 6644-6648.
34. Mao, C., Vig, R., Venkatachalam, T. K, Sudbeck, E. A., and Uckun, F. M. (1998) Structure-Based Design of N-[2-(1-piperidinylethyl)]-N′-[2-(5-bromopyridyl)]thiourea and N-[2-(1-piperazinylethyl)]-N′-[2-(5-bromopyridyl)]thiourea as Potent Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase. Bioorg. Med. Chem. Lett. 8, 2213-2218.
35. Olson, A. J., and Goodsell, D. S. (1998) Automated Docking and the Search for HIV Protease Inhibitors. SAR QSAR Environ. Res. 8, 273-285.
36. Kamata, Y., Yoshimoto, M., and Kozaki, S. (1997) Interaction Between Botulinum Neurotoxin Type A and Ganglioside: Ganglioside Inactivates the Neurotoxin and Quenches Its Fluorescence. Toxicon 35, 1337-1340.
37. Lacy, D. B., and Stevens, R. C. (1999) Sequence Homolgy and Structural Analysis of the Clostridial Neurotoxins. J. Mol. Biol. 291, 1091-1104.
38. Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., and Whitehouse, C. M. (1989) Electrospray Ionization For Mass Spectrometry of Large Biomolecules. Science 246, 64-71.
39. Dole, M., Mack, L. L., Hines, R. L., Mobley, R. C., Ferguson, L. D., and Alice, M. B. (1968) Molecular Beams of Macroions. J. Chem. Phys. 49, 2240-2249.
40. Ganem, B., Li, Y.-T., and Henion, J. D. (1991) Detection of Noncovalent Receptor-Ligand Complexes by Mass Spectrometry. J. Am. Chem. Soc. 113, 6294-6296.
41. Katta, V., and Chait, B. T. (1991) Observation of the Heme-Globin Complex in Native Myoglobin by Electrospray-Ionization Mass Spectrometry. J. Am. Chem. Soc. 113, 8534-8535.
42. Loo, J. A. (1997) Studying Noncovalent Protein Complexes by Electrospray Ionization Mass Spectrometry. Mass Spectrom. Rev. 16, 1-23.
43. Smith, R. D., Bruce, J. E., Wu, Q., and Lei, Q. P. (1997) New mass spectrometric methods for the study of noncovalent associations of biopolymers. Chem. Soc. Rev. 26, 191-202.
44. McLafferty, F. W. (1981) Tandem Mass Spectrometry. Science 214, 280-287.
45. Gaskell, S. J. (1997) Electrospray: Principles and Practice. J. Mass Spectrom. 32, 677-688.
46. Roe, D. C., and Kuntz, I. D. (1995) What is Struture-Based Drug Design? Pharm. News 2, 13-15.
47. O'Connell, M. A., Belanger, B. A., and Haaland, P. D. (1993) Calibration and Assay Development Using the Four-Parameter Logistic Model. Chemom. Intell. Lab. Syst. 20, 97-114.
48. Beilstein (1999) Beilstein Information Systems, Inc., San Leandro, CA.